A review of the treatment of chronic hepatitis C virus infection in cirrhosis
Authors:
- Alessio AghemoAAAlessio Aghemo
- Massimo ColomboMCMassimo Colombo
- 1 December 2010
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 32 (13) , 2117-2138
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Ribavirin Improves Early Responses to Peginterferon Through Improved Interferon SignalingGastroenterology, 2010
- Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C InfectionNew England Journal of Medicine, 2009
- Sustained virological responses following standard anti‐viral therapy in decompensated HCV‐infected cirrhotic patientsAlimentary Pharmacology & Therapeutics, 2009
- Diagnosis, management, and treatment of hepatitis C: An update # † ‡Hepatology, 2009
- A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis CJournal of Hepatology, 2007
- Report of the Monothematic EASL Conference on Liver Transplantation for Viral HepatitisJournal of Hepatology, 2006
- High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?: Table 1Gut, 2006
- Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combinationJournal of Hepatology, 2004
- Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type CJournal of Hepatology, 1997
- An Algorithm for the Grading of Activity in Chronic Hepatitis CHepatology, 1996